Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial)
Mohd Shazli Draman(Nilai University), Colin Dayan(University of Birmingham), Daniel S. Morris(University Hospital of Wales), Onyebuchi Okosieme(Cwm Taf University Health Board), Peter Taylor(University Hospital of Wales), Pakinee Pooprasert(Cardiff University), Marian Ludgate(Cardiff University), Rosemary Greenwood, Lei Zhang(Zhejiang University of Science and Technology), Carol Lane(University Hospital of Wales), Chris Foy(Gloucestershire Hospitals NHS Foundation Trust), Anjana Haridas(University Hospital of Wales), Julie Pell(Cardiff University), Sam Evans(University Hospital of Wales), Ilaria Muller(University of Milan)
Cited by 17
Related Papers
Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
|JAMA|2019|395
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
|Nature Reviews Endocrinology|2019|315
Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and Risks
|JAMA Internal Medicine|2013|299